Efficacy and Safety of 24 Weeks of Therapy with Bendroflumethiazide 1.25 mg/day or 2.5 mg/day and Potassium Chloride Compared with Enalapril 10 mg/day and Amlodipine 5 mg/day in Patients with Mild to Moderate Primary Hypertension: A Multicentre, Randomised, Open Study

By Rasmussen S.  

Clinical Drug Investigation, Vol. 26, Iss. 2, 2006-01 ,pp. : 91-101

Adis International

Access to resources Recommend Favorite

Efficacy and Tolerability of Lacosamide in the Concomitant Treatment of 130 Patients Under 16 Years of Age with Refractory Epilepsy: A Prospective, Open-Label, Observational, Multicenter Study in Spain

By Casas-Fernández Carlos  

Drugs in R&D, Vol. 12, Iss. 4, 2012-12 ,pp. : 187-197

Adis International

Access to resources Recommend Favorite

Oral L-Ornithine-L-Aspartate Improves Health-Related Quality of Life in Cirrhotic Patients with Hepatic Encephalopathy: An Open-Label, Prospective, Multicentre Observational Study

By Ong Janus P.   Oehler Gerd  

Clinical Drug Investigation, Vol. 31, Iss. 4, 2011-04 ,pp. : 213-220

Adis International

Access to resources Recommend Favorite

Perindopril for Control of Blood Pressure in Patients with Hypertension and Other Cardiovascular Risk Factors: An Open-Label, Observational, Multicentre, General Practice-Based Study

By Richard Ian Ogilvie  

Clinical Drug Investigation, Vol. 28, Iss. 11, 2008-01 ,pp. : 673-686

Adis International

Access to resources Recommend Favorite

Antihypertensive Effect of Irbesartan and Predictors of Response in Obesity-Associated Hypertension: A Prospective, Open-Label Study

By Sharma Arya M.  

Clinical Drug Investigation, Vol. 25, Iss. 12, 2005-01 ,pp. : 765-776

Adis International

Access to resources Recommend Favorite